IMUX Long Call Strategy
IMUX (Immunic, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
IMUX (Immunic, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $127.8M, a beta of 1.21 versus the broader market, a 52-week range of 5.06-15.1, average daily share volume of 309K, a public-listing history dating back to 2014, approximately 91 full-time employees. These structural characteristics shape how IMUX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.21 places IMUX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long call on IMUX?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current IMUX snapshot
As of May 15, 2026, spot at $12.23, ATM IV 124.10%, IV rank 25.97%, expected move 35.58%. The long call on IMUX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on IMUX specifically: IMUX IV at 124.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a IMUX long call, with a market-implied 1-standard-deviation move of approximately 35.58% (roughly $4.35 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IMUX expiries trade a higher absolute premium for lower per-day decay. Position sizing on IMUX should anchor to the underlying notional of $12.23 per share and to the trader's directional view on IMUX stock.
IMUX long call setup
The IMUX long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IMUX near $12.23, the first option leg uses a $12.23 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IMUX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IMUX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $12.23 | N/A |
IMUX long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
IMUX long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on IMUX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on IMUX
Long calls on IMUX express a bullish thesis with defined risk; traders use them ahead of IMUX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
IMUX thesis for this long call
The market-implied 1-standard-deviation range for IMUX extends from approximately $7.88 on the downside to $16.58 on the upside. A IMUX long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current IMUX IV rank near 25.97% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IMUX at 124.10%. As a Healthcare name, IMUX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IMUX-specific events.
IMUX long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IMUX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IMUX alongside the broader basket even when IMUX-specific fundamentals are unchanged. Long-premium structures like a long call on IMUX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current IMUX chain quotes before placing a trade.
Frequently asked questions
- What is a long call on IMUX?
- A long call on IMUX is the long call strategy applied to IMUX (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With IMUX stock trading near $12.23, the strikes shown on this page are snapped to the nearest listed IMUX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IMUX long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the IMUX long call priced from the end-of-day chain at a 30-day expiry (ATM IV 124.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IMUX long call?
- The breakeven for the IMUX long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IMUX market-implied 1-standard-deviation expected move is approximately 35.58%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on IMUX?
- Long calls on IMUX express a bullish thesis with defined risk; traders use them ahead of IMUX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current IMUX implied volatility affect this long call?
- IMUX ATM IV is at 124.10% with IV rank near 25.97%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.